Review: Surfactant protein D: A lung specific biomarker in COPD?

A major impediment in the development of novel drugs for chronic obstructive pulmonary disease (COPD) has been the scarcity of a well-validated, robust, and easily obtainable intermediate end point such as serum biomarkers. To date the best serum biomarkers in COPD have been non-speci“c pro-in”ammat...

Full description

Bibliographic Details
Main Authors: Don D. Sin, Payam S. Pahlavan, S.F. Paul Man
Format: Article
Language:English
Published: SAGE Publishing 2008-04-01
Series:Therapeutic Advances in Respiratory Disease
Online Access:https://doi.org/10.1177/1753465808088903